Recruitment and Characterization of Healthy Research Volunteers for NIMH Intramural Studies

NCT ID: NCT03304665

Last Updated: 2025-08-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

2000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-11-01

Study Completion Date

2028-03-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Objective: To screen and create a list of adult volunteers in good health for participation in research studies conducted at the National Institutes of Health (NIH) in Bethesda, Maryland. Develop a normative set of structural and functional brain MRI scans that are linked to healthy research volunteer characteristics. Maximize scientific impact of data from volunteers by broadly sharing with other researchers.

Study Population: Adult males and females in general good health who are 18 years of age and older.

Design: Adult individuals who are interested in participating in NIMH IRP clinical studies as a healthy research volunteer can directly visit or be directed to visit the study website where they will first consent electronically and then complete a set of online self-report measures. Items may include: demographic information, mental health symptoms, disability status, substance use patterns, handedness and clinical/family history. Individuals who are flagged based on predetermined responses to survey items will be further screened by a member of the study clinical team. If found to be ineligible for the study because of a clinically significant or unstable medical or mental health condition, these individuals will be referred back to the community and/or given information about NIMH clinical studies for which they may be eligible. Respondents with no flags or who pass through additional screening will be scheduled for an in-person assessment. During the outpatient appointment and after in-person informed consent, participants will receive a brief clinical interview to screen for current medical and mental conditions, and risk for self-harm. They will complete assessments of psychological, emotional, physiologic, biological and cognitive functioning. Participants will undergo a physical exam and be asked to provide blood and urine samples for routine clinical labs. Participants can separately consent for an optional baseline brain magnetic resonance imaging (MRI) scan and an optional magnetoencephalography (MEG) exam. All consent forms will explicitly inform participants that if enrolled in the study, their de-identified data will be broadly and publicly shared through NIH-approved data repositories. Participants in this recruitment and characterization study will then be placed on a list of healthy research volunteers from which other NIMH IRP studies may recruit according to the inclusion and exclusion criteria in their respective IRB-approved protocols.

Outcome Measures: Outcome measures may include demographic data, mental and medical history and symptoms, results of psychological, emotional, physiologic, biological, and cognitive testing, physical exam and MRI findings....

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Objective: To screen and create a list of adult volunteers in good health for participation in research studies conducted at the National Institute of Mental Health (NIMH) in Bethesda, Maryland. Develop a normative set of structural and functional brain MRI scans and MEG recordings that are linked to healthy research volunteer characteristics. Maximize scientific impact of data from volunteers by broadly sharing with other researchers.

Study Population: Adult males and females in general good health who are 18 to 70 years of age.

Design:

This study has 2 parts. Part 1 is an online screen in which interested participants are asked to complete online forms that will help determine their eligibility for Part 2, which is an in-person assessment at the NIH Clinical Center. In addition, there are 3 optional procedures, an optional MRI brain scan, MEG recording, and electrocardiography (EKG) that are completed at the NIH Clinical Center. Procedures are done in sequence unless a person is found to be ineligible to move to the next step.

Adult individuals who are interested in participating in NIMH IRP clinical studies as a healthy research volunteer can directly visit or be directed to visit the study website where they will first consent electronically and then complete a set of online self-report measures. Items may include: demographic information, mental health symptoms, psychological measures, disability status, substance use patterns, and clinical/family history. Individuals who are flagged based on predetermined responses to survey items may be further screened by a member of the study clinical team. If found to be ineligible for the study because of a clinically significant or unstable medical or mental health condition, these individuals will be referred back to the community and/or given information about NIMH clinical studies for which they may be eligible. Respondents with no flags or who pass through additional screening will be eligible for a clinical (in-person) assessment at the NIH Clinical Center. During the in-person outpatient appointment the participant will provide informed consent for the clinical assessment and optional MRI and MEG studies. At that point they are considered enrolled in the study. The clinical assessment may include safety assessment, vital signs, history and physical, labs, cognitive tests, mental health surveys, and structured psychiatric diagnostic interview.

Some assessments may be conducted either in-person or virtually using approved telehealth services. Laboratory tests will be done for routine clinical purposes. The consent form will explicitly inform participants that if enrolled in the study, their de-identified data will be broadly and publicly shared through NIH-approved data repositories. Participants in this recruitment and characterization study may then be placed on a list of healthy research volunteers and their contact information may be shared with other NIMH IRP studies.

Outcome Measures:

* Primary outcome measure - List of well characterized healthy volunteers including demographic, psychological, physical, laboratory, MEG, and MRI data; and utilization of volunteer participants by NIMH IRP investigators.
* Secondary outcome measure - Upload of de-identified healthy volunteer characterization data to an open access data repository for secondary research purposes; data may include demographic, psychological, physical, laboratory, MEG, and MRI measures.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Volunteer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Healthy Volunteers

Healthy Volunteers

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 - 70 years of age.
* Able to read, speak, and understand English.
* Able to provide informed consent.
* In current good general health.

Exclusion Criteria

* Have a history of significant or unstable medical or mental health condition requiring treatment, such as heart or lung disease, depression or psychosis.
* Endorse current self-injury, suicidal thoughts or behavior.
* Have current illicit drug use by history or urine drug screen.
* Are found to have an abnormal physical exam or laboratory result that may require treatment or further evaluation.
* Less than an 8th grade education.
* Pregnancy.
* Positive HIV test as HIV positivity has been associated with neurological changes.


* Metal in body which would make having an MRI scan unsafe.
* Being uncomfortable in small, closed spaces such as the MRI machine.
* Inability to lie comfortably on back for at least 45 minutes.
* Pregnancy.


-Metal in body which would cause artifacts on MEG recordings.
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institute of Mental Health (NIMH)

NIH

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Carlos A Zarate, M.D.

Role: PRINCIPAL_INVESTIGATOR

National Institute of Mental Health (NIMH)

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

National Institutes of Health Clinical Center

Bethesda, Maryland, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Carlos A Zarate, M.D.

Role: CONTACT

(301) 326-5836

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

NIH Clinical Center Office of Patient Recruitment (OPR)

Role: primary

800-411-1222 ext. TTY dial 711

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

17-M-0181

Identifier Type: -

Identifier Source: secondary_id

170181

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.